IGHE and airway hyperresponsiveness: This was evidenced by the increase in immunoglobulins (IgE, IgG1), airway hyperresponsiveness (Rn and FEV0.1), increase in peribronchial inflammatory cell accumulation, and increased gene and protein expression of different TH2/TH17 pathway members and mediators.